Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$384M |
| 2 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$293M |
| 3 |
Walmart Inc
WMT
|
+$242M |
| 4 |
UN
Unilever NV New York Registry Shares
UN
|
+$220M |
| 5 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$436M |
| 2 |
Home Depot
HD
|
+$261M |
| 3 |
Walt Disney
DIS
|
+$236M |
| 4 |
JPMorgan Chase
JPM
|
+$230M |
| 5 |
Comcast
CMCSA
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.23% |
| 2 | Technology | 13.84% |
| 3 | Healthcare | 11.95% |
| 4 | Consumer Discretionary | 8.3% |
| 5 | Consumer Staples | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
451
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.33M | ﹤0.01% |
39,852
+26,416
| +197% | +$1.67M |
|
452
Zillow
Z
$7.71B
| $2.3M | ﹤0.01% |
56,100
| – | – |
|
|
MCHB
453
Mechanics Bancorp
MCHB
$3.68B
| $2.25M | ﹤0.01% |
77,592
-8,959
| -10% | -$260K |
|
454
Southside Bancshares
SBSI
$960M
| $2.24M | ﹤0.01% |
66,398
-5,533
| -8% | -$196K |
|
|
LMNX
455
DELISTED
Luminex Corp
LMNX
| $2.2M | ﹤0.01% |
111,693
+15,190
| +16% | +$316K |
|
456
Heron Therapeutics
HRTX
$94.1M
| $2.19M | ﹤0.01% |
121,069
+20,705
| +21% | +$338K |
|
457
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.98B
| $2.13M | ﹤0.01% |
81,704
-13,667
| -14% | -$357K |
|
|
DHC
458
Diversified Healthcare Trust
DHC
$2.17B
| $2.08M | ﹤0.01% |
108,400
| – | – |
|
|
ARRY
459
DELISTED
Array Biopharma Inc
ARRY
| $2.07M | ﹤0.01% |
161,433
+27,253
| +20% | +$310K |
|
460
Banc of California
BANC
$2.91B
| $1.96M | ﹤0.01% |
94,951
-22,197
| -19% | -$464K |
|
|
CNCE
461
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.94M | ﹤0.01% |
74,839
| – | – |
|
|
IFX
462
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
| $1.92M | ﹤0.01% |
70,106
-5,322
| -7% | -$146K |
|
|
ACET
463
DELISTED
Aceto Corp
ACET
| $1.92M | ﹤0.01% |
185,709
+31,041
| +20% | +$326K |
|
464
Booking.com
BKNG
$150B
| $1.91M | ﹤0.01% |
27,450
+1,375
| +5% | +$99.6K |
|
465
Stewart Information Services
STC
$2.08B
| $1.87M | ﹤0.01% |
44,266
-801
| -2% | -$31.6K |
|
466
Travere Therapeutics
TVTX
$5.33B
| $1.85M | ﹤0.01% |
87,905
+12,260
| +16% | +$280K |
|
|
IRBT
467
DELISTED
iRobot
IRBT
| $1.85M | ﹤0.01% |
24,069
| – | – |
|
468
Clorox
CLX
$11.7B
| $1.82M | ﹤0.01% |
12,222
+995
| +9% | +$135K |
|
|
PGNX
469
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.81M | ﹤0.01% |
303,692
+51,762
| +21% | +$314K |
|
470
SLB Ltd
SLB
$72.6B
| $1.8M | ﹤0.01% |
26,711
-5,966
| -18% | -$387K |
|
471
iShares Core S&P 500 ETF
IVV
$872B
| $1.8M | ﹤0.01% |
6,688
+5,356
| +402% | +$1.4M |
|
472
VanEck Vietnam ETF
VNM
$502M
| $1.79M | ﹤0.01% |
100,100
| – | – |
|
|
BFX
473
DELISTED
BowFlex Inc.
BFX
| $1.77M | ﹤0.01% |
132,742
+18,340
| +16% | +$266K |
|
474
Hanmi Financial
HAFC
$940M
| $1.75M | ﹤0.01% |
57,508
-17,010
| -23% | -$525K |
|
|
MNTA
475
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.74M | ﹤0.01% |
124,507
+25,984
| +26% | +$351K |
|
Similar funds
Ken Fisher's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Fisher held 984 positions worth $76.6B, up 7.4% from $71.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Fisher's Q4 2017 filing shows 141 new, 329 increased, 331 reduced and 62 closed positions. Its largest new stake was HITACHI LTD ADR (10COM)NEW: 925,930 shares worth $72.2M. The largest sale was Bank of America, an estimated $436M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q4 2017 buy was HITACHI LTD ADR (10COM)NEW: 925,930 shares worth $72.2M.
- Ken Fisher added most to Costco in Q4 2017, an estimated $384M increase.
- Ken Fisher's biggest Q4 2017 reduction was Bank of America, cutting an estimated $436M.
- Ken Fisher fully exited Harley-Davidson in Q4 2017, selling an estimated $4.17M.
- Ken Fisher's ten largest holdings make up 24% of its $76.6B portfolio in Q4 2017.
- Ken Fisher opened 141 new positions and closed 62 in Q4 2017.
- Ken Fisher's portfolio value rose 7.4% quarter-over-quarter to $76.6B.
Based on Fisher Asset Management's 13F filing for Q4 2017, filed 24 Jan 2018.